Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU4-8P is a non-coding RNA classified as a pseudogene related to the U4 small nuclear RNA gene family. Unlike functional U4 genes (such as RNU4-2), which code for small nuclear RNA involved in the spliceosome and mRNA processing, RNU4-8P is a non-functional genomic sequence with no proven biological activity. Pseudogenes do not produce functional RNA or protein products and are generally considered to be evolutionary remnants. RNU4-8P is a pseudogene and does not produce a functional small nuclear RNA used in spliceosome assembly, unlike functional U4 genes (notably RNU4-2). There is no evidence RNU4-8P is or could be a therapeutic target (not a receptor, enzyme, transporter, or similar druggable entity). Recent groundbreaking literature and disease associations focus on functional variants of RNU4-2 (not RNU4-8P), where mutations have been shown to cause a high-prevalence monogenic neurodevelopmental syndrome. None of these works refer to RNU4-8P as the disease-causing entity. If you are seeking the splicing snRNA gene implicated in neurodevelopmental disease, the correct target is RNU4-2, not RNU4-8P. In summary, RNU4-8P is not an active molecule or valid therapeutic/diagnostic target. It is a pseudogene for a member of the U4 small nuclear RNA family, with no known function, therapeutic relevance, or disease involvement. If your intention was to identify the functional U4 snRNA implicated in neurodevelopmental disorders, RNU4-2 is the correct gene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U4 small nuclear 8, pseudogene (RNU4-8P).